Cancer Researcher Ramon E. Parsons, MD, PhD, Joins Mount Sinai
Ramon E. Parsons, MD, PhD, a highly acclaimed researcher in cancer genetics, has joined Icahn School of Medicine at Mount Sinai as the Ward-Coleman Chair in Cancer, and Chair of the Department of Oncological Sciences. Dr. Parsons succeeds Stuart Aaronson, MD, Jack and...
New Myelofibrosis Drug Holds Promise
In a phase I clinical trial, physicians at The Mount Sinai Medical Center have identified the first drug that appears to stop the progression of myelofibrosis, a life-threatening blood cancer. The investigators found that, at low-doses, panobinostat (LBH589)...
Roger J. Hajjar, MD, To Be Honored for Research
Roger J. Hajjar, MD, a pioneering Mount Sinai researcher who has published cutting-edge studies on heart failure, has been named the recipient of the 2013 BCVS Distinguished Achievement Award by the American Heart Association and the Council on Basic Cardiovascular...
Breaking Through Autism
The Center for Disease Control and Prevention has found that 1 in 88 people are affected by autism spectrum disorders (ASD), a disorder four times more common in boys than in girls. At the Seaver Autism Center for Research and Treatment, we are dedicated to...
Is Marijuana Harmless?
Marijuana (Cannabis sativa) is the illicit drug most commonly used by teenagers in the United States. Although cannabis is not as addictive as other substances, such as heroin and cocaine, cannabis-dependent individuals still greatly outnumber those reporting...
Rapid Treatment for the Depressed Brain
Is it possible to rapidly elevate the depressed mood? This has been a pressing question over the past 50 years because classic antidepressants, such as Prozac, are known to take weeks to reach clinical efficacy; combining medications to enhance antidepressant outcomes...
Treating Depression More Rapidly & Effectively
The prevalence rate for depression in the United States is nearly 7%, yet standard antidepressants produce full remission in only 30-40% of patients. Even when treatment is effective, patients require 2-4 weeks to achieve the full therapeutic effects. Adding to the...
Novel Study Links High-Sugar Diet to Heart Disease
A novel study of high-sugar consumption in Drosophila fruit flies is leading researchers at Icahn School of Medicine at Mount Sinai to a greater understanding of diabetes-related heart disease, and to therapeutic targets that could ultimately prevent arrhythmia,...
Department of Psychiatry Opens New Center
The Department of Psychiatry at Icahn School of Medicine at Mount Sinai has opened a new center to investigate and treat tics, obsessive compulsive disorder (OCD), and related disorders, which are estimated to affect more than 2 million people in the United States....